Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis

  • Expert Opin Investig Drugs. 2019 Jun;28(6):501-504. doi: 10.1080/13543784.2019.1618269.
Fabio Barra  1  2 ,  Andrea Romano  3 ,  Giovanni Grandi  4 ,  Fabio Facchinetti  4 ,  Simone Ferrero  1  2
Affiliations
  • 1. a Academic Unit of Obstetrics and Gynecology , IRCCS Ospedale Policlinico San Martino , Genoa , Italy.
  • 2. b Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI) , University of Genoa , Genoa Italy.
  • 3. c Department of Gynaecology and Obstetrics, GROW - School for Oncology & Developmental Biology , Maastricht University , Maastricht , the Netherlands.
  • 4. d Department of Obstetrics, Gynecology and Pediatrics, Obstetrics and Gynecology Unit, Azienda Ospedaliero-Universitaria Policlinico , University of Modena and Reggio Emilia , Modena , Italy.
PMID: 31072144 DOI: 10.1080/13543784.2019.1618269
Keywords
17β-hydroxysteroid dehydrogenase 1; AKR1C3; Endometriosis; aromatase inhibitors; estrogen biosynthesis; steroid sulphatase.
Products